Tech Company Financing Transactions
MedaRed Funding Round
MedaRed closed a $6.5 million Seed financing round on 7/9/2019. Investors included Dementia Discovery Fund, Dolby Family Ventures and private investors.
Transaction Overview
Company Name
Announced On
7/9/2019
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Seed
Investors
Dementia Discovery Fund (Lead Investor)
Dolby Family Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds to develop these molecules into therapeutics that target fibrin for people with diseases that have significant unmet clinical need. The initial focus will be on Alzheimer's disease (AD) and multiple sclerosis (MS).
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1650 Owens St. 259
San Francisco, CA 94158
USA
San Francisco, CA 94158
USA
Phone
Email Address
Not Recorded
Overview
MedaRed, Inc. develops an antibody that targets fibrin, to make it similar to human antibodies and suitable for use as a therapeutic strategy to protect the nervous system to people living with Multiple Sclerosis (MS). The company was founded in 2016 and is based in San Francisco, California.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Burgess
President
Edward Spack
Browse more venture capital transactions:
Prev: 7/9/2019: 15Five venture capital transaction
Next: 7/9/2019: Kaleidoscope Labs venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs